Announce Date | 02/27/2025 |
EPS Normalized Actual | $1.65 (Miss by $-0.01) |
EPS GAAP Actual | $1.65 (Miss by $-0.01) |
Revenue Actual | $1.9078B |
Revenue Surprise | Beat by $1907.8M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.86514 |
EPS GAAP Estimate | $2.86514 |
Revenue Estimate | $2.75345105B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0 | INF | 0 | 0 | 2 |
Dec 2027 | 9.19 | 13.51 | 8.87369 | 9.54131 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.7 | -0.7 | 1.9078B | -0.24% | 1907.8M |
FQ4 2024 (Dec 2024) | 1.34 | 1.34 | 2.4036B | 4.33% | 2403.6M |
FQ2 2024 (Jun 2024) | 2.03 | 2.03 | 2.6746B | 6.39% | 2674.6M |
FQ3 2024 (Sep 2024) | 2.34 | 2.34 | 2.7726B | 6.79% | 2772.6M |
FQ4 2023 (Dec 2023) | 1.5 | 1.5 | 2.2995B | 100% | 2299.5M |
FQ1 2024 (Mar 2024) | 0.0881 | 0.0881 | 1.9124B | 9.42% | 1912.4M |
FQ3 2023 (Sep 2023) | -4.16 | -4.16 | 2.5843B | 6.54% | 2584.3M |
FQ2 2023 (Jun 2023) | 2.02 | 2.02 | 2.5037B | 5.81% | 2503.7M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.86514
Consensus Revenue Estimates
2.75345105B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.68 | -- | 2.54019 | 2.92953 | 2 |
FQ3 2027 (Sep 2027) | 3.46 | -- | 3.2795 | 3.78215 | 2 |
FQ2 2027 (Jun 2027) | 3.08 | -- | 2.91932 | 3.36677 | 2 |
FQ1 2027 (Mar 2027) | -0.01 | -- | -0.01093107 | -0.00947831 | 2 |
FQ4 2026 (Oct 2026) | 2.58 | -- | 2.48421 | 2.65873 | 4 |
FQ3 2026 (Jul 2026) | 2.71 | -- | 2.60938 | 2.7927 | 4 |
FQ2 2026 (Jun 2026) | 2.6963 | -- | 2.59419 | 2.7684 | 4 |
FQ1 2026 (Mar 2026) | 0.4257 | 264.44 | 0.40958 | 0.43708 | 4 |
FQ4 2025 (Oct 2025) | 3.01483 | 55.55 | 2.9029 | 3.10683 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.78B | -- | 2.66B | 2.97B | 7 |
FQ3 2027 (Sep 2027) | 3.1B | -- | 2.98B | 3.32B | 4 |
FQ2 2027 (Jun 2027) | 2.95B | -- | 2.83B | 3.16B | 4 |
FQ1 2027 (Mar 2027) | 1.99B | -- | 1.91B | 2.13B | 7 |
FQ4 2026 (Oct 2026) | 2.81B | -- | 2.73B | 2.88B | 5 |
FQ3 2026 (Jul 2026) | 2.87B | -- | 2.79B | 2.94B | 5 |
FQ2 2026 (Jun 2026) | 2.84B | -- | 2.75B | 2.89B | 5 |
FQ1 2026 (Mar 2026) | 2.03B | 6.02 | 1.97B | 2.07B | 5 |
FQ4 2025 (Oct 2025) | 2.8B | 14.24 | 2.72B | 2.87B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.7 | -0.7 | 100% | |
FQ4 2024 (Dec 2024) | 1.34 | 1.34 | 100% | |
FQ2 2024 (Jun 2024) | 2.03 | 2.03 | 100% | |
FQ3 2024 (Sep 2024) | 2.34 | 2.34 | 100% | |
FQ4 2023 (Dec 2023) | 1.5 | 1.5 | 100% | |
FQ1 2024 (Mar 2024) | 0.0881 | 0.0881 | 100% | |
FQ3 2023 (Sep 2023) | -4.16 | -4.16 | 100% | |
FQ2 2023 (Jun 2023) | 2.02 | 2.02 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.91B | $1907.8M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.4B | $2403.6M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.67B | $2674.6M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.77B | $2772.6M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.3B | $2299.5M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.91B | $1912.4M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.58B | $2584.3M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.5B | $2503.7M | 100% |